Healthcare Provider Investments: Key Points For Regulatory Due Diligence


Private equity investments in healthcare providers have grown exponentially in recent years as investors see the high potential for profitability in the industry. Nonetheless, it is important for investors to keep in mind that healthcare entities are subject to numerous laws and regulations, including, without limitation, fraud and abuse laws. Apart from the expense of defending against allegations of fraud and abuse, the sanctions and penalties authorised by the fraud and abuse laws may prove devastating to a healthcare entity and its investors.

An investor seeking to make an acquisition of part of, or all of, a healthcare entity, should carefully conduct healthcare regulatory due diligence of the target and prudently structure the transaction in compliance with applicable laws before closing on the deal.

Originally published in Financier Worldwide - February 2014.

Please see full Article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Topics:  Compliance, Due Diligence, Healthcare, Healthcare Fraud, Healthcare Reform

Published In: General Business Updates, Finance & Banking Updates, Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McCarter & English, LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »